Benefits Plans - Prescription Drug Plan: Drug Plan Updates and New Drug Releases - Drug Reviews

Page last updated: Wednesday, 26-May-2010 20:51:25 EDT

March 2003

Following are the drug considerations that were reviewed and determined for formulary inclusion and tier placement by the U-M Pharmaceutical Benefits Advisory Committee. The chart combines the January, February and March 2003 drug releases.

Drug Name Indication Preferred Drug List Action
Altocor Cholesterol Yes Tier 3
Augmentin XR Infections Yes Tier 3
Depo-Testosterone Androgen Replacement Therapy No Tier 3, quantity limit
Hepsera Hepatitis B Infection No Tier 2, PA*
Lexapro Depression Yes Tier 3, review data in 6 months
Omnicef Infections Yes Tier 2
Suprax Infections Yes Remove from formulary - product discontinued
Vfend Aspergillosis Infections No Tier 2, monitor utilization
Xyrem Narcolepsy associated cataplexy No Tier 2
Zelnorm Irritable Bowel Syndrome No Tier 2, monitor utilization
Avandamet Diabetes Yes Tier 2
Avodart Benign Prostatic Hyperplasia Yes Tier 2
Cipro XR Acute Cystitis Yes Tier 2; quantity limit
Forteo Osteoporosis Yes Tier 2
Humira Rheumatoid Arthritis No Tier 2 with PA*
Metaglip Diabetes Yes Tier 3
Pegasys Chronic Hepatitis C No Tier 2
Stratterra ADHD No Tier 3
Zetia Cholesterol Yes Tier 2
Abilify Schizophrenia No Tier 3

*PA = Prior Authorization

Limitations
The University of Michigan in its sole discretion may modify, amend, or terminate the benefits provided with respect to any individual receiving benefits, including active employees, retirees, and their dependents. Although the university has elected to provide these benefits this year, no individual has a vested right to any of the benefits provided. Nothing in these materials gives any individual the right to continued benefits beyond the time the university modifies, amends, or terminates the benefit. Anyone seeking or accepting any of the benefits provided will be deemed to have accepted the terms of the benefits programs and the university's right to modify, amend or terminate them.